Wecome Pharmaceutical Co Ltd (300878) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.001x

Based on the latest financial reports, Wecome Pharmaceutical Co Ltd (300878) has a cash flow conversion efficiency ratio of -0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.42 Million ≈ $-208.32K USD) by net assets (CN¥1.03 Billion ≈ $150.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Wecome Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Wecome Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 300878 total debt and obligations for a breakdown of total debt and financial obligations.

Wecome Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wecome Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Contrel Technology Co Ltd TWO:8064	0.088x
ZJBC Information Technology Co Ltd SHE:000889	0.056x
Tongqinglou Dining Co Ltd SHG:605108	N/A
Sturm Ruger & Company Inc NYSE:RGR	0.046x
iQIYI Inc F:IQ8	-0.020x
Shanghai Labway Clinical Laboratory Co Ltd SHE:301060	0.081x
Poly Union Chemical Holding Group Co Ltd SHE:002037	0.014x
Tipco Asphalt Public Company Limited F:NVP5	0.092x

Annual Cash Flow Conversion Efficiency for Wecome Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Wecome Pharmaceutical Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Wecome Pharmaceutical Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.17 Billion ≈ $171.77 Million	CN¥-27.17 Million ≈ $-3.98 Million	-0.023x	-155.89%
2023-12-31	CN¥1.41 Billion ≈ $205.95 Million	CN¥58.29 Million ≈ $8.53 Million	0.041x	-60.11%
2022-12-31	CN¥1.41 Billion ≈ $206.55 Million	CN¥146.57 Million ≈ $21.45 Million	0.104x	+315.97%
2021-12-31	CN¥1.41 Billion ≈ $206.18 Million	CN¥-67.74 Million ≈ $-9.91 Million	-0.048x	-255.47%
2020-12-31	CN¥1.38 Billion ≈ $202.58 Million	CN¥42.81 Million ≈ $6.26 Million	0.031x	-85.74%
2019-12-31	CN¥519.84 Million ≈ $76.07 Million	CN¥112.76 Million ≈ $16.50 Million	0.217x	-19.08%
2018-12-31	CN¥393.83 Million ≈ $57.63 Million	CN¥105.57 Million ≈ $15.45 Million	0.268x	+182.87%
2017-12-31	CN¥306.05 Million ≈ $44.79 Million	CN¥29.00 Million ≈ $4.24 Million	0.095x	-80.04%
2016-12-31	CN¥210.90 Million ≈ $30.86 Million	CN¥100.15 Million ≈ $14.66 Million	0.475x	+108.41%
2015-12-31	CN¥130.04 Million ≈ $19.03 Million	CN¥29.63 Million ≈ $4.34 Million	0.228x	-61.26%
2014-12-31	CN¥78.22 Million ≈ $11.45 Million	CN¥46.01 Million ≈ $6.73 Million	0.588x	-22.24%
2013-12-31	CN¥34.35 Million ≈ $5.03 Million	CN¥25.98 Million ≈ $3.80 Million	0.756x	--

About Wecome Pharmaceutical Co Ltd

SHE:300878 China Biotechnology

Market Cap

$605.54 Million

CN¥4.14 Billion CNY

Market Cap Rank

#11558 Global

#3518 in China

Share Price

CN¥28.58

Change (1 day)

+3.93%

52-Week Range

CN¥14.81 - CN¥35.33

All Time High

CN¥52.21